Structural basis of immunosuppression by the therapeutic antibody daclizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Structural basis of immunosuppression by the therapeutic antibody daclizumab

Published:2010-09-07 Issue:12 Volume:20 Page:1361-1371
ISSN:1001-0602
Container-title:Cell Research
language:en
Short-container-title:Cell Res

Author:

Yang Hui,Wang Jianchuan,Du Jiamu,Zhong Chen,Zhang Dapeng,Guo Huaizu,Guo Yajun,Ding Jianping

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/cr2010130.pdf

Reference62 articles.

1. Smith KA . Interleukin-2: inception, impact, and implications. Science 1988; 240:1169–1176.

2. Nelson BH, Willerford DM . Biology of the interleukin-2 receptor. Adv Immunol 1998; 70:1–81.

3. Klebb G, Autenrieth IB, Haber H, et al. Interleukin-2 is indispensable for development of immunological self-tolerance. Clin Immunol Immunopathol 1996; 81:282–286.

4. Robb RJ, Munck A, Smith KA . T cell growth factor receptors. Quantitation, specificity, and biological relevance. J Exp Med 1981; 154:1455–1474.

5. Rickert M, Wang X, Boulanger MJ, Goriatcheva N, Garcia KC . The structure of interleukin-2 complexed with its alpha receptor. Science 2005; 308:1477–1480.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Theiler’s murine encephalomyelitis virus in treatment of multiple sclerosis;Frontiers in Microbiology;2024-06-26

2. Non‐IL‐2‐blocking anti‐CD25 antibody inhibits tumor growth by depleting Tregs and has synergistic effects with anti‐CTLA‐4 therapy;International Journal of Cancer;2024-01-05

3. Improving de novo protein binder design with deep learning;Nature Communications;2023-05-06

4. CD25 : A potential tumor therapeutic target;International Journal of Cancer;2022-10

5. Improving de novo Protein Binder Design with Deep Learning;2022-06-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3